Clinical trial

Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics

NCT02922179

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-01-01

PhaseN/A

Study timeline

Study start (actual)2011-01-01Date precision: day

Registry last updated2021-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

Long- and intermediate- acting insulinsDRUG

Sponsors & collaborators

Biologics & Biosimilars Collective Intelligence Consortiumlead sponsor

HealthCore, Inc.collaborator

Aetna, Inc.collaborator

University of Alabama; Rheumatologist and Healthcare Researchcollaborator

AbbViecollaborator

Amgencollaborator

Boehringer Ingelheimcollaborator

Kaiser Permanentecollaborator

Harvard Pilgrim Health Carecollaborator

Merck Sharp & Dohme LLCcollaborator

Momenta Pharmaceuticals, Inc.collaborator

Pfizercollaborator

University of Pittsburghcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02922179 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.